Pharmacological Management of Osteoporosis in Postmenopausal Women Guideline Resources | Endocrine Society
Clinical Practice Guideline

Pharmacological Management of Osteoporosis in Postmenopausal Women Guideline Resources

March 19, 2019

Full Guideline: Pharmacological Management of Osteoporosis in Postmenopausal Women
JCEM: May 2019 (online March 2019)

Richard Eastell, Clifford J. Rosen (chair), Dennis M. Black, Angela M. Cheung, M. Hassan Murad, and Dolores Shoback

The 2019 guideline on pharmacological management of osteoporosis in postmenopausal women:

  • Provides recommendations for the treatment and management of osteoporosis in postmenopausal women
  • Emphasizes assessment after being on treatments to see if further treatment is necessary



Resources

Guideline Introduction | ENDO 2019


Essential Points

  • Treat high risk individuals - particularly those with previous fracture.
  • Consider bisphosphonates as the first line therapeutic choice for postmenopausal women at high risk of fracture.
  • Reassess fracture risk after patient has been on bisphosphonates for 3-5 years.
  • Following reassessment, prescribe a “bisphosphonate holiday” for women who are on bisphosphonates and are low-to-moderate risk of fracture.
  • Consider anabolic therapy (teriparatide or abaloparatide) for women at very high risk of fractures, including those with multiple fractures.
  • All women undergoing treatment with osteoporosis therapies other than anabolic therapy should consume calcium and vitamin D in their diet or via supplements.
  • Monitor the BMD of high-risk individuals with a low BMD every 1 to 3 years.


List of Recommendations

+ 1.0 Who to Treat

+ 2.0 Bisphosphonates

+ 3.0 Denosumab

+ 4.0 Teriparatide and Abaloparatide—Parathyroid Hormone and Parathyroid Hormone-Related Protein (PTHrP) Analogs

+ 5.0 Selective Estrogen Receptor Modulators

+ 6.0 Menopausal Hormone Therapy and Tibolone

+ 7.0 Calcitonin

+ 8.0 Calcium and Vitamin D

+ 11.0 Monitoring

On the Go

CPG Mobile App

CPG Mobile App Sample screen
Access guideline recommendations, patient information, and clinical education modules for a range of endocrine topics plus dozens of interactive decision algorithms and other point-of-care tools.

Download our CPG Mobile App

Access guideline recommendations, patient information, and clinical education modules for a range of endocrine topics plus dozens of interactive decision algorithms and other point-of-care tools.

On the Go

GUIDELINES Pocket Guides

Pocket Guides
Practical quick-reference tools to help you make accurate clinical decisions at the point of care.

Practical quick-reference tools to help you make accurate clinical decisions at the point of care.

ENDO 2020

Maximize Your Savings

Register Today
Bringing together leading experts, researchers, and the most respected clinicians in the field, ENDO represents a convergence of science and practice that highlights and facilitates breakthrough discoveries in the field of endocrinology.

Early Registration Deadline: December 12, 2019

Bringing together leading experts, researchers, and the most respected clinicians in the field, ENDO represents a convergence of science and practice that highlights and facilitates breakthrough discoveries in the field of endocrinology.

Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!